Continuous Glucose Monitors Help Type 2 Diabetes Patients Achieve 5 More Hours Daily in Healthy Blood Sugar Range

A groundbreaking study published in the New England Journal of Medicine reveals that continuous glucose monitors (CGMs) could significantly improve diabetes management for millions of Americans with type 2 diabetes who don't use insulin. Research shows that CGM users spend approximately 5 additional hours per day maintaining healthy blood sugar levels compared to standard monitoring methods. This finding represents a major advancement in diabetes care, offering patients real-time glucose tracking that enables better decision-making about diet, activity, and medication management. For type 2 diabetes patients, CGMs provide continuous data that helps prevent dangerous blood sugar fluctuations and reduce long-term complications, making this technology potentially transformative for quality of life and health outcomes.